News and Media

Media Mentions

More mentions

Novel allergen inhibitor successfully prevents peanut reaction in mice

As Ba┼čar Bilgiçer co-author of the study explained, the reality is that “in the case of peanut allergy, there is no pathogen, just peanut proteins.”

Peanut allergy drug staves off anaphylaxis for 2 weeks with a single dose

“These new findings suggest that cHBI has the potential to be an effective preventative for peanut-specific allergic responses in patients,” said co-senior author Basar Bilgicer, Ph.D.

Severe peanut allergy breakthrough by Indiana University and Notre Dame researchers

Professor Basar Bilgicer and his students have been hard at work on this project. It's one he's been invested in since 2008 and it's not a program that could've been rushed.

Originally published at news.nd.edu.

Severe peanut allergy breakthrough by Indiana University and Notre Dame researchers

“Sometimes, we do have quantum leaps and make a huge discovery that may take us from one point to the next in a single experiment. this is not one of them, we had to take small steps every day to keep moving, just like the story of the tortoise and the hare,” said Basar Bilgicer, professor of chemical and biomolecular engineering at Notre Dame.

Peanut Allergies are on the Rise. This Chemical Compound Could Prevent Life-Threatening Reactions.

“Our method is a high precision tool that can block the responsible [immune molecules] and nothing else,” Bilgicer says. “Hopefully, that means it will start working from day one.”